Close
Patheon

Corporate Videos

 
27 OCTOBER 2017
The Journey from Molecule to Medicine
It all starts with your discovery. A molecule, small or large, that needs a partner. Let Patheon be that partner.
SHARE
26 OCTOBER 2017
Better Together
Leon Wyszkowski, President of the Clinical Trials Division of Thermo Fisher Scientific, discusses the value of Patheon and Fisher Clinical Services joining together to provide integrated solutions for our clients.
SHARE
25 OCTOBER 2017
"I am Proud"
Patheon employees share their excitement about becoming part of Thermo Fisher Scientific and the first truly integrated, end-to-end CDMO solution.
SHARE
25 OCTOBER 2017
You Inspire Us Every Day
Michel Lagarde, President of Pharma Services, Thermo Fisher Scientific, discusses why Pharma Services employees are so passionate about partnering with small and emerging biopharma clients.
SHARE
25 OCTOBER 2017
Fulfilling our Mission
Michel Lagarde, President of Pharma Services, Thermo Fisher Scientific, shares how the combination of Patheon with Thermo Fisher brings unique value to biopharma clients and the patients they serve.
SHARE
21 FEBRUARY 2017
Welcome to the World of Patheon
Patheon is the #1 provider of pharmaceutical development services. Learn more about Patheon's longstanding history of manufacturing and development expertise.
SHARE
6 OCTOBER 2016
Patheon CEO James Mullen shares insights about how Patheon is tailoring solutions to customer needs
Patheon CEO James Mullen talks about unique business models that are changing the CDMO industry.
SHARE
5 OCTOBER 2016
Franco Negron provides an overview of Patheon's flexible manufacturing solutions
Franco Negron, Patheon's president of drug product services, provides an overview of Patheon's flexible manufacturing solutions designed to meet customers' key challenges around forecasting and managing capacity. Flexible manufacturing allows for faster implementation and lower capital expense.
SHARE
1 AUGUST 2016
Patheon is now listed on the NYSE (PTHN)
Patheon CEO James Mullen & the entire Patheon family are pleased to announce that Patheon is now listed on the New York Stock Exchange as PTHN!
SHARE
13 OCTOBER 2015
Chris Tama, SVP, Marketing, brings to life the new Patheon branding
Chris describes the concept behind the new tagline, A Healthier World. Delivered. He also showcases the importance of the Patheon staff who make medicines and deliver them to the patient who are waiting – visualized by the Maker’s Hand.
SHARE
13 OCTOBER 2015
Mike Lehmann shares an interesting perspective about partnerships and trust
Mike Lehmann, President, Global PDS and EVP Global Sales & Marketing, describes what he is hearing from clients at the CPhI 2015 meeting in Madrid – what they are seeking from companies like Patheon.
SHARE
13 OCTOBER 2015
Franco Negron shares his view about clients’ need for flexible resourcing and end-to-end solutions
Franco Negron, Sr. Vice President, North America Commercial Operations and Global Integration, from the CPhI 2015 annual meeting in Madrid shared his view about clients’ need for flexible resourcing and end-to-end solutions. Franco talks about how Patheon is uniquely positioned to meet the breadth of customer needs.
SHARE
28 SEPTEMBER 2015
Patheon – Contract Drug Development & Pharmaceutical Manufacturing for Pharmaceutical Companies
Patheon is transforming drug development and pharmaceutical manufacturing with a simplified, end-to-end supply chain solution for pharmaceutical companies and biopharm companies of all sizes. Drug substances and drug products. Drug development and drug manufacturing. API and biologics. Sterile, oral solid and softgel dosage forms. Patheon offers a comprehensive range of services spanning all drug development phases and scales that is wider and deeper than that of any other CDMO.
SHARE
2 NOVEMBER 2017
How can pharma companies save up to $45M in early drug development?
Patheon's Jennifer Therrien discusses findings of a Tufts Center for the Study of Drug Development (CSDD) study that reveals how pharmaceutical companies using a single-source outsourcing partner can achieve a net gain of $45 million in early drug development.
SHARE
12 JANUARY 2016
Amanda Bosse explains how Patheon delivers a unique Client Service Model
Once your project goes inside, who’s on your side? Business Management: Your bridge from start to success. Most companies in the industry employ the typical two-part service model: Outside sales then inside service. But between the two is a gap where project details, critical time and opportunities for efficiency can get lost. Gaps can also appear as a project moves from one stage to the next. Patheon takes a different approach with our global business management team. Got a minute? That’s all it takes Amanda Bosse, VP Business Management, Global Drug Product Services, to give an overview how our business management team elevates the client experience by keeping their needs front and center throughout a project.
SHARE
14 OCTOBER 2015
Joe Principe shares his view on demand forecasting and flexible capacity
Joe Principe, Patheon’s VP, Global Alliance Accounts, spoke about demand forecasting and delivering flexible capacity solutions to clients at the CPhI 2015 meeting in Madrid. Principe reinforces the critical importance of flexibility in demand forecast planning. Patheon has developed some modeling around flexible manufacturing and capacity analysis and business models to address that. He says, clients are looking for predictability and customized solutions.
SHARE
14 OCTOBER 2015
Marshall Crew explains how experts can help solve the challenge of solubility
Marshall Crew, from Patheon, focuses on solubility and shares as molecules have become more complex how experts can help solve the challenge of solubility for clients.
SHARE